Site InfectionNCT07476261
Incidence of Ssi After c.s
An observational study of Site Infection, run by Assiut University at 1 site in Egypt.
Trial summary
aim of the work is to evaluate adherence to preoperative , intraoperative, and postoperative infection preventive measures during cesarean section and to assess it s impact on the incidence of surgical site infection and maternal well-being during 30 days postoperative peroid. Read more about this study
- Who is it for?
- Ages 18 to 45 years, women only
- Conditions the study is for
- Site Infection
- How many people
- 105 participants
- Where
- 1 siteEgypt
- Study dates
- 1 May 2026to 1 Aug 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- Adult
Study population: The study population will include all women undergoing Cesarean Section at El-Mabarra Health Insurance Hospital during the study period. Eligible participants will be followed for 30 days after delivery to detect the occurrence of Surgical Site Infection. Women who meet the inclusion criteria and agree to participate in the study will be enrolled consecutively until the required sample size is reached.
Who may be able to join
- All women who underwent cesarean section during the study period
Who cannot join
- Patients who are lost to follow-up before completion of the 30-day postoperative assessment.
- Patients with immunocompromised conditions, such as:
- Chronic corticosteroid therapy. Immunosuppressive treatment. Known HIV infection with severe immunosuppression .
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Incidence of Surgical Site Infection After Cesarean Section and Compliance With Surgical Site Infection Prevention Stratigies .
aim of the work is to evaluate adherence to preoperative , intraoperative, and postoperative infection preventive measures during cesarean section and to assess it s impact on the incidence of surgical site infection and maternal well-being during 30 days postoperative peroid.
Read the detailed description
Cesarean Section is one of the most commonly performed obstetric surgical procedures worldwide. Despite its importance in reducing maternal and fetal complications, it is associated with several postoperative complications, the most important of which is Surgical Site Infection. Surgical site infection after cesarean section can lead to increased maternal morbidity, prolonged hospital stay, and higher healthcare costs. Therefore, evaluating the incidence of surgical site infection and assessing adherence to preventive measures are essential for improving the quality of obstetric care. This study aims to determine the incidence of surgical site infection after cesarean section and to assess compliance with infection prevention strategies.
- Conditions
- Site Infection
What is being measured
The primary outcome is the main question the study is designed to answer.
incidence of surgical site infection after cesarean section
superficial or deep surgical site infection
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Mar 2026
- Study start1 May 2026 (estimated)
- Primary completion1 May 2027 (estimated)
- Study completion1 Aug 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Site InfectionStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 105 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, mona magdy helmy, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07476261
- Sponsor's protocol ID
- ssi after c.s
- Status last verified
- Mar 2026
- First submitted
- 12 Mar 2026
- Last updated
- 17 Mar 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Naeem A, et al. Incidence of surgical site infection after cesarean section. 2025.
Study at a glance
From the registry record, last updated by the sponsor on 17 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Incidence of Surgical Site Infection After Cesarean Section and Compliance With Surgical Site Infection Prevention Stratigies .
- ClinicalTrials.gov ID
- NCT07476261
- Acronym / sponsor ID
- ssi after c.s
- Conditions
- Site Infection
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 105 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 1 May 2026 (estimated)
- Primary completion
- 1 May 2027 (estimated)
- Study completion
- 1 Aug 2027 (estimated)
- First posted
- 17 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
aim of the work is to evaluate adherence to preoperative , intraoperative, and postoperative infection preventive measures during cesarean section and to assess it s impact on the incidence of surgical site infection and maternal well-being during 30 days postoperative peroid.
Detailed description
Cesarean Section is one of the most commonly performed obstetric surgical procedures worldwide. Despite its importance in reducing maternal and fetal complications, it is associated with several postoperative complications, the most important of which is Surgical Site Infection. Surgical site infection after cesarean section can lead to increased maternal morbidity, prolonged hospital stay, and higher healthcare costs. Therefore, evaluating the incidence of surgical site infection and assessing adherence to preventive measures are essential for improving the quality of obstetric care. This study aims to determine the incidence of surgical site infection after cesarean section and to assess compliance with infection prevention strategies.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Age groups
- Adult
- Study population
- The study population will include all women undergoing Cesarean Section at El-Mabarra Health Insurance Hospital during the study period. Eligible participants will be followed for 30 days after delivery to detect the occurrence of Surgical Site Infection. Women who meet the inclusion criteria and agree to participate in the study will be enrolled consecutively until the required sample size is reached.
Key inclusion criteria (1 listed)
- All women who underwent cesarean section during the study period
Key exclusion criteria (3 listed)
- Patients who are lost to follow-up before completion of the 30-day postoperative assessment.
- Chronic corticosteroid therapy. Immunosuppressive treatment. Known HIV infection with severe immunosuppression .
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
incidence of surgical site infection after cesarean section
Time frame: Baseline
superficial or deep surgical site infection
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Mar 2026.
- BackgroundNaeem A, et al. Incidence of surgical site infection after cesarean section. 2025.
Related trials for Site Infection
Not yet recruitingObservational study
Pilot Study on the Effectiveness and Safety of OPTILENE® SILVER MESH ELASTIC in Prevention of Surgical Site Infection (SSI) and Incisional Hernia (IH)
Abdominal Aortic Aneurysm, Morbid Obesity
RecruitingObservational study
Cohort of Women Living With HIV-1 and Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide
HIV (Human Immunodeficiency Virus), Pregnancy
Not yet recruitingPhase 2
Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)
Respiratory Recurrent Papillomatosis (RRP), Human Papillomavirus (HPV)
Active, not recruiting
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis
RecruitingPhase 2
A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
Head and Neck Cancer, Head and Neck Squamous Cell Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Site Infection, run by Assiut University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 17 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact mona madgy (01145421696, mona.helmy1997@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
incidence of surgical site infection after cesarean section (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07476261, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Mar 2026.